Valuation: Getinge AB

Market Cap 68.96B 6.88B 6.16B 5.74B 5.21B 9.82B 657B 9.88B 27B 339B 25.83B 25.26B 1,092B P/E 2026 *
21.8x
P/E 2027 * 19.4x
Enterprise Value 77.17B 7.69B 6.89B 6.42B 5.82B 10.99B 736B 11.05B 30.21B 380B 28.9B 28.26B 1,221B EV / Sales 2026 *
2.18x
EV / Sales 2027 * 2x
Free-Float
79.13%
Yield 2026 *
2.05%
Yield 2027 * 2.23%
1 day+1.55%
1 week+4.61%
Current month+3.94%
1 month+7.59%
3 months+20.04%
6 months+31.50%
Current year+13.55%
1 week 22.04
Extreme 22.04
22.67
1 month 20.71
Extreme 20.71
22.67
Current year 16.36
Extreme 16.355
22.67
1 year 16.36
Extreme 16.355
22.67
3 years 14.23
Extreme 14.23
22.67
5 years 14.23
Extreme 14.23
42.95
10 years 7.17
Extreme 7.168
42.95
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO 48 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.57%+4.61% - - 6.9B
+2.10%+1.51%-22.66%+12.66% 172B
+3.83%+4.41%-3.90%+28.84% 113B
+1.56%-1.26%-22.83%+10.94% 106B
+0.27%+1.56%-46.56%-11.83% 75.31B
+0.62%+3.49%+2.82%+73.76% 61.8B
+0.12%+3.62%+15.06%+62.75% 52.93B
+2.09%+3.94%+0.60%-26.95% 50.05B
+1.10%-0.56%-17.24%+22.37% 40.81B
-1.03%+0.50% - - 31.81B
Average +1.22%+2.43%-11.84%+21.57% 78.29B
Weighted average by Cap. +1.62%+2.34%-14.84%+19.56%

Financials

2026 *2027 *
Net sales 35.35B 3.53B 3.16B 2.94B 2.67B 5.03B 337B 5.06B 13.84B 174B 13.24B 12.95B 560B 37.54B 3.74B 3.35B 3.12B 2.83B 5.34B 358B 5.38B 14.7B 185B 14.06B 13.75B 594B
Net income 3.18B 317M 284M 265M 240M 453M 30.32B 456M 1.25B 15.65B 1.19B 1.17B 50.35B 3.59B 358M 321M 299M 271M 511M 34.23B 514M 1.41B 17.66B 1.35B 1.32B 56.84B
Net Debt 8.21B 818M 732M 683M 619M 1.17B 78.21B 1.18B 3.21B 40.36B 3.07B 3.01B 130B 6.02B 600M 538M 501M 455M 857M 57.4B 863M 2.36B 29.62B 2.26B 2.21B 95.32B
Projected Income Statement - Annual - Getinge AB
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change
26-10-12 €22.67 +1.61%
26-10-09 €22.31 +0.90%
26-10-08 €22.11 +0.32%
26-10-07 €22.04 -0.54%
26-10-06 €22.16 +2.26%
Trader
Investor
Global
Quality
ESG MSCI
B
Ratings Surperformance© - Getinge AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
253.20SEK
Average target price
252.20SEK
Spread / Average Target
-0.39%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Getinge AB